Back

Pharma

Sustainable Medicine & Environment Online Conference

  • 16th February 2023
  • ONLINE flag ONLINE Zoom

Sustainability plays a significant role in the development of health care and a greener/better future. At this online conference, we want to discuss measures to control costs in a way commensurate with quality medical care, the regulatory landscape, optimisation of the supply chain, identifying and solving difficult points in healthcare packaging, and cutting carbon emissions on the manufacturing side with care for the planet.

Learn best practices on how to adapt to the difficult changes in the economy while achieving cost-efficiency and best quality in pharmaceutical production.

Expand your knowledge on February 16th, 2023, at the Sustainable Medicine & Environment Online Conference.

Read more

About the Sustainable Medicine & Environment Online Conference 

This online conference will target sustainability in life science and healthcare, as it's important to focus on regulations and new trends for greener pharmaceutical manufacturing.

Join the interactive discussion on the optimisation of the supply chain and cutting carbon emissions in production, as well as developing and manufacturing more sustainable materials.

Experts will talk about how to identify and solve difficult points in healthcare packaging and ways to minimise environmental impacts without compromising healthcare outcomes and safety.

Join us online on February 16th, 2023, and learn from well-known experts in the field.

 

Who Should Attend 

Executives, Directors, Heads, Leaders, Managers, Specialists, Engineers Professionals in Pharmaceuticals, Principal Scientists, Sustainable Regulatory, QC Laboratories, Manufacturers of Drug Substances (APIs), Contract Laboratories, Health & Human Services, Clinical Research Org., Healthcare Packaging, Contract Research Org., Contract Manufacturing Org., Biopharma Companies, Biotechnology Prod., and Fellows specialising in:  

 

  • Regulatory Affairs 
  • Waist Control 
  • Recycling 
  • Eco-Friendly Manufacturing 
  • Container Development 
  • Compliance 
  • Labelling 
  • Environment  
  • Manufacturing Science and Technology 
  • Parenterals 
  • Product and Process Development 
  • Risk Management 
  • Safety Assessments 
  • Supply Chain 
  • Technology Transfer   
  • Controls & Robotics 
  • Drug Development 
  • Materials Science & Selection 
  • Medical Devices 
  • Standardisation 
  • Vaccines  
  • Validation   
  • Production  
  • EHS    
  • QA/QC   
  • CMC   
  • CMO/CDMO   
  • Other  

 

REQUEST A BROCHURE

To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.

Key Practical Learning Points

  • Sustainability measures in medicine as part of strategy to reduce carbon emissions 
  • Care for environment as a simultaneous benefit to human health 
  • Low-carbon healthcare systems 
  • Waste control: disposal of expired products, antibiotics, etc.   
  • Healthcare sustainability opportunities, practices, and challenges 
  • Sustainability in medical device design 
  • Sustainability initiatives in life sciences packaging and proper disposal 
  • Low-carbon emissions in production and supply chains: recyclable vs. recoverable 
  • Multidisciplinary efforts for sustainability in healthcare (MESH) 
  • Implementation of energy-efficient equipment  
  • Collaboration with OEM: speed, cost, and technologies aspects 

Dr. Ester Lovsin, CH

Global Head Product Sustainability and Stewardship

Takeda

Ester Lovsin Barle, DVM, MSc, PhD, MScTox is the global head of product sustainability and stewardship and at Takeda Pharmaceuticals. She lives in Zurich, Switzerland.

Ester is passionate about generating value with product safety and sustainability. She is leading the cross-organizational product sustainability workstream sustainability by design for the planet pillar of purpose-led sustainability in Takeda. Her responsibilities also include product stewardship topics, such as safety data sheet process, maintaining article and material regulatory compliance and scientific development and cross-organisational implementation of health-based exposure limits (HBEL) in support of research and manufacturing in Takeda globally. Previously she has held corporate positions at Lonza and Novartis. She has been working in the pharmaceutical industry for over 15 years. She received her PhD in veterinary sciences from University of Ljubljana, Slovenia, and a second master’s degree in toxicology and risk assessment from Medical University in Vienna. Ester is a certified toxicologist.

Dr. Jan Backmann MSc, CH

Head Chemical Legislation

F.Hoffmann-La Roche Ltd

Dr. Jan Backmann leads the chemical legislation unit of the multinational healthcare company F.Hoffmann-La Roche Ltd. (Basel, Switzerland). After earning his MSc in chemistry, he worked at Robert-Koch Institute Berlin (German Federal Health Office) and completed his doctorate at Berlin Free University. He conducted postdoctoral research at the University of Brussels and the Flemish Institute of Biotechnology (Belgium). This was followed by a position at the International Soap and Detergent Association A.I.S.E., located in Brussels. Afterwards, Jan worked in the Swiss contract research organisation RCC Ltd. as well as in the chemical companies Ciba and BASF. His special interests are in the field of chemical policy and sustainable chemistry.

Dr. Michael Hell, DE

Head of Environmental Sustainability, Global Healthcare Operations

Merck Healthcare KGaA

Dr. Michael Hell is a chemist (MSc) and cell biologist (PhD) by education with substantial experience in manufacturing and operations of biopharmaceuticals. Before being appointed to head of sustainability at Merck’s Healthcare operations, he was leading environment, health, and safety for Merck KGaA’s global biotech manufacturing and led a packaging, logistics, and visual inspection operation unit.

Michael brings a diverse background in manufacturing, spanning environment, health, and safety, strategy development, continuous improvement/LEAN, operations, and business consulting. He is an active member of ISPE and chaired conference tracks or contributed as speaker. Michael co-authored scientific papers or book chapters.

Fabrice Gallou, CH

Distinguished Scientist – Chemical & Analytical Development

Novartis

Fabrice Gallou received his PhD from Ohio State University in the field of natural products total synthesis. He then joined the chemical development at Boehringer Ingelheim, USA, working as a process chemist responsible for route scouting and supply of early phase programs. He subsequently moved to the chemical development group at Novartis, Switzerland, as a process development chemist, and rapidly became responsible for global scientific activities, overseeing development and implementation of practical and economical chemical processes for large scale production of APIs. His research interests rely on the research and development of sustainable synthetic methodologies intended for large-scale implementation. He published more than 250 peer-reviewed papers, book chapters, and patents.

Sebastian Gerner, CH

President of Alliance to Zero/Corporate Sustainability Manager

Ypsomed AG

Sebastian Gerner is corporate sustainability manager with Ypsomed Delivery Systems and president of the Alliance to Zero. He is driving the transition of Ypsomed from a linear take-make-waste economy towards a circular economy. He is a mechanical engineer with more than 10 years of medical device experience in various medical and pharmaceutical companies.

Thomas Hauser, DE

Business Development Manager EMEA

G-CON Manufacturing

Thomas Hauser works for G-CON Manufacturing in a business development assignment in the EMEA region to educate the market for offsite prefabricated and prequalified factory and clean-room solutions in a drive to bring forward the pharmaceutical facility of the future concept.

On the other hand, he supports companies in the life science segment mainly for expansion strategies, strategical facility implementation, startup support, and pharmaceutical packaging supply and technologies.

Before 2020, Thomas worked in various leading global positions in business development, strategic implementation, and sales in the pharmaceutical packaging field, namely in injectables and semi-solid and oral-solid packaging. He has more than 25 years of experience dealing with the global life science industry and its market and manufacturing requirements.

Thomas holds an international MBA from the University of Ottawa, Canada, and a BA for European business from the ESB Reutlingen and the ESC Reims.

Jürgen Wieland, CH

Global Drug Development Environmental Sustainability Lead

Novartis Pharma AG

Novartis has set ambitious environmental sustainability targets to achieve carbon neutral own operations by 2025, plastic neutrality and water sustainability by 2030, and net-zero by 2040.

Jürgen’s role as environmental sustainability lead for global drug development covers the set-up and execution of low carbon clinical trials. On top, Jürgen is in charge of the company-wide target of “all new products meet sustainable design principles by 2030”, which spans from research up to commercial.

Jürgen has been very engaged and passionate about the topic of environmental sustainability for more than three decades. Prior to joining Novartis in 2011, he was the CFO of the NGO Solar Energy Foundation, supporting the roll-out of solar energy in rural East Africa. From 2015-20, he was the finance head of Novartis’ global clinical supply unit, during which he was awarded with the Novartis “Better World Award for Environmental Sustainability” for significant progress in the decarbonisation of clinical trials. Jürgen contributes beyond Novartis within the UK-based Sustainable Healthcare Coalition to the industries’ low carbon clinical trial workstream.

Dr. Ester Lovsin, CH

Global Head Product Sustainability and Stewardship

Takeda

Dr. Jan Backmann MSc, CH

Head Chemical Legislation

F.Hoffmann-La Roche Ltd

Dr. Michael Hell, DE

Head of Environmental Sustainability, Global Healthcare Operations

Merck Healthcare KGaA

Fabrice Gallou, CH

Distinguished Scientist – Chemical & Analytical Development

Novartis

Sebastian Gerner, CH

President of Alliance to Zero/Corporate Sustainability Manager

Ypsomed AG

Thomas Hauser, DE

Business Development Manager EMEA

G-CON Manufacturing

Jürgen Wieland, CH

Global Drug Development Environmental Sustainability Lead

Novartis Pharma AG

BROCHURE

Request the Sustainable Medicine & Environment Online Conference brochure and find out the latest topics and ideas that will be shared.  

Request

Please fill in your e-mail address below and we will process your request in a moment.